Latest Breaking News On - சாரா ஃபேகி - Page 16 : comparemela.com

DGAP-News: CureVac kündigt den Abschluss des öffentlichen Zeichnungsangebots mit einem Erlös von 450 Millionen US-Dollar an

DGAP-News: CureVac kündigt den Abschluss des öffentlichen Zeichnungsangebots mit einem Erlös von 450 Millionen US-Dollar an
boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesEdgar gniCurevac thorstenSarah fakihCompany isPrinciple of curevacs technologyJefferies llcUbs investment bankProspectus departmentEquity syndicate prospectus departmentA serviceBofa securitiesGuggenheim securitiesSecurities hasOffer was

CureVac AG: CureVac Announces Pricing of $450 million Follow-on Public Offering of Common Shares

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 28, 2021 / CureVac N.V. (Nasdaq: CVAC) ("CureVac" or the "Company"), a global biopharmaceutical company developing a new class of transformative

New yorkUnited statesSarah fakihExchange commissionProspectus departmentEquity syndicate prospectus departmentKempen coEvercore groupInvestment bankGuggenheim securitiesBofa securitiesCollege streetEquity capital marketsNew york nasdaqVice president investorVice president

CureVac Announces Pricing of $450 million Follow-on Public Offering of Common Shares

Press release content from Accesswire. The AP news staff was not involved in its creation.

New yorkUnited statesSarah fakihExchange commissionProspectus departmentEquity syndicate prospectus departmentKempen coEvercore groupInvestment bankGuggenheim securitiesBofa securitiesCollege streetEquity capital marketsNew york nasdaqVice president investorVice president

PRESS RELEASE : CureVac Announces Pricing of USD450 million Follow-on Public Offering of Common Shares

DGAP-News: CureVac / Key word: Financing/Corporate Action CureVac Announces Pricing of USD450 million Follow-on Public Offering of Common Shares 2021-01-28 / 07:00 The issuer is solely responsible.

New yorkUnited statesSarah fakihKempen coInvestment bankDistribution servicesExchange commissionProspectus departmentEquity syndicate prospectus departmentCommunications curevacEvercore groupCorporate actionCurevac announces pricingFollow on public offeringCommon sharesVac announces pricing

CureVac NV: CureVac Announces Proposed Public Offering of Common Shares

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 25, 2021 / CureVac N.V. (NASDAQ:CVAC) ("CureVac" or the "Company"), a global biopharmaceutical company developing a new class of transformative medicines

New yorkUnited statesSarah fakihExchange commissionProspectus departmentEquity syndicate prospectus departmentKempen coEvercore groupInvestment bankGuggenheim securitiesBofa securitiesCollege streetEquity capital marketsNew york nasdaqVice president investorVice president